SE367181

1320181 Cyclic carboxylic acid amides TAKEDA YAKUHIN KOGYO KK 14 May 1970 [14 May 1969 25 Dec 1969 26 Dec 1969 18 April 1970 (2)] 23344/70 Heading C2C Novel compounds Ia in which R 1 is 1-6 C alkyl or 3-6 C cycloalkyl; R 3 is H or 1-4 C alkyl; X is halogen and n is 2 or 3 are prepared by (1) reactio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KISHIMOTO S,JA, MINAMIDA I,JA, NOGUCHI S,JA, KAWAI K,JA, OBAYASHI M,JA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1320181 Cyclic carboxylic acid amides TAKEDA YAKUHIN KOGYO KK 14 May 1970 [14 May 1969 25 Dec 1969 26 Dec 1969 18 April 1970 (2)] 23344/70 Heading C2C Novel compounds Ia in which R 1 is 1-6 C alkyl or 3-6 C cycloalkyl; R 3 is H or 1-4 C alkyl; X is halogen and n is 2 or 3 are prepared by (1) reaction of the corresponding acid or its anhydride, ester or halide with NH 3 ; or (2) by reduction of a compound IVa in which R 4 is H or halogen followed where R 4 is H by halogenation; or (3) by alkylation of a compound Ia in which R 3 is H. Compounds VI in which R 5 is alkyl and R 6 is cyano or alkoxycarbonyl are prepared by reacting compounds VII with compounds of formula X1-(CH 2 ) n-1 -R 6 where X1 is halogen or with compounds CH 2 = CHR 6 . Compounds III are prepared by hydrolysis and decarboxylation of compounds VI. Ethyl 2 - cyano - 3 - (p - cyclohexylphenyl) - 2- butenoate (A) is prepared by reaction of p-cyclohexylacetophenone and ethyl cyanoacetate. By reaction of A with KCN, followed by hydrolysis of the product 2-methyl-2-(p-cyclohexylphenyl)- succinic acid is prepared. The anhydrides of III are prepared by reaction of III with acetic anhydride. Cyclization of the anhydrides of III gives compounds VIII which are claimed per se in Specification 1,320,182. Reduction of compounds VIII gives compounds V (in which R 2 is OH) some of which are claimed per se in Specifications 1,320,183 and 1,320,184. Compounds V in which R 4 is H may be halogenated to give compounds V in which R 4 is halogen. Compounds V in which R 3 is H may be alkylated to give compounds V in which R 3 is alkyl. Compounds V may be esterified to give their esters. Pharmaceutical compositions for oral or parenteral administration comprise a compound Ia and a suitable excipient and are useful as analgesics, antipyretics, anti-inflammatory agents and antirheumatic agents.